Stability of salivary microRNA measures across an NCAA Division I football season: Implications for microRNA as a biomarker of concussion
PLOS One · 2026
DOI: 10.1371/journal.pone.0339614 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Thomas R Campbell und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Rehabilitation Sciences, Ellmer College of Health Sciences, Old Dominion University, Norfolk, Virginia, United States of America. Hauptthemen laut MEDLINE: MicroRNAs, Brain Concussion, Saliva, Football. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clinicians often face challenges in concussion care due to a heavy reliance on subjective patient input. Recently, research has sought objective biomarkers, like salivary microRNAs, to improve concussion management. However, significant limitations hinder the use of microRNAs as a diagnostic tool, including the cumulative effects of a contact sport season. A better understanding of the response to a contact sport season would help researchers and clinicians interpret expression changes at the time of injury in the context of seasonal variation. in Therefore, this study investigated the reliability of previously identified salivary microRNA targets across one contact sport season.
Methods
This longitudinal study involved 50 male NCAA Division I football players (21 ± 1.6 years; 187.5 ± 6.9 cm; 103.1 ± 19.8 kg). Saliva was collected before the season’s first contact practice and within 72 hours of the season’s final game. Quantitative polymerase chain reaction (qPCR) experiments were conducted using pre-selected microRNA targets. Non-parametric tests compared expressions between time points (α ≤ 0.05).
Results
No significant differences were found between pre- and post-season miRNA ( p = .07−.46). However, intraclass correlation coefficients revealed low to moderate reliability across the season (ICC = −.04−.65).
Conclusions
Our study found no significant differences in time points for target microRNA, but ICC statistics indicated low reliability across the season. These findings suggest that microRNA expression may be variable throughout the season regardless of concussive trauma, and clinicians should be aware that changes in microRNA expression should not be directly attributed to concussive forces. Researchers and clinicians should not rely on the presented set of microRNA to make clinical decisions for potential concussive injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Rehabilitation Sciences, Ellmer College of Health Sciences, Old Dominion University, Norfolk, Virginia, United States of America.
- Macon and Joan Brock Virginia Health Sciences, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, United States of America.
- School of Medical Diagnostic and Translational Sciences, Ellmer College of Health Sciences, Old Dominion University, Norfolk, Virginia, United States of America.
ORCID-Profile: Thomas R Campbell, Peter A Mollica
Zitieren
APA
Campbell, T. R., Zamponi, M., Leathers, D., Cavallario, J., Martinez, J. C., & Mollica, P. A. (2026). Stability of salivary microRNA measures across an NCAA Division I football season: Implications for microRNA as a biomarker of concussion. PLOS One. https://doi.org/10.1371/journal.pone.0339614
Vancouver
Campbell TR, Zamponi M, Leathers D, Cavallario J, Martinez JC, Mollica PA. Stability of salivary microRNA measures across an NCAA Division I football season: Implications for microRNA as a biomarker of concussion. PLOS One. 2026. doi:10.1371/journal.pone.0339614
BibTeX
@article{Campbell2026,
author = {Campbell, Thomas R and Zamponi, Martina and Leathers, Delaney and Cavallario, Julie and Martinez, Jessica C and Mollica, Peter A},
title = {Stability of salivary microRNA measures across an NCAA Division I football season: Implications for microRNA as a biomarker of concussion},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0339614}
}
EUVIMED